|
阿吡莫德甲磺酸盐市场分析报告
|
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... 1-7, Angiotensin receptor blocker, Anluohuaxian, AOIM - Z , Apilimod Dimesylate , Apixaban, APL-9, apocynin, Apremilast ... , Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, Ceftriaxone ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... 1-7, Angiotensin receptor blocker, Anluohuaxian, AOIM - Z , Apilimod Dimesylate , Apixaban, APL-9, apocynin, Apremilast ... , Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, Ceftriaxone ...
|
|
|